ArticleNeuro-oncology2022

Heterogeneity and excitability of BRAFV600E-induced tumors is determined by Akt/mTOR-signaling state and Trp53-loss.

Silvia Cases-Cunillera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.